Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash
Accounts receivable	22,433	21,664
Inventory, current portion	19,544	23,866
Other receivable	5,000
Convertible notes receivable, net of discount	6,600	225,396
Receivable from sale of Stemsation stocks	35,200
Investment in Stemsation stocks	35,200
Settlement receivables	160,084
Prepaid expenses and other current assets	29,999	62,651
Total current assets	314,060	333,577
Inventory, less current portion	125,170	80,570
Property and equipment, net	17,842	80,012
Operating lease right-of-use assets, net	174,522	251,951
Security deposit	8,803	8,803
Total assets	640,397	754,913
Current liabilities:
Accounts payable	762,955	727,367
Accrued expenses	1,900,497	1,678,027
Accrued payroll due to officers	1,373,693	1,213,693
Deferred revenue - related party	233,331	181,515
Accrued interest to related parties	168,724	149,909
Due to officer	659,433	112,046
Derivative liabilities	661,257	629,579
Other debt, net of discount, current portion	8,321,801	7,930,918
SBA notes payable, current portion	6,243	2,930
Operating lease obligations, current portion	83,703	74,837
Total current liabilities	14,171,637	12,700,821
Notes payable, less current portion		105,640
Convertible note, less current portion		1,820
SBA notes payable, less current portion	143,657	146,970
Operating lease obligations, less current portion	93,411	177,114
Total liabilities	14,408,705	13,132,365
Commitments and Contingencies (Note 13)
Stockholders’ deficit:
Preferred stock, $0.001 par value, 20,000,000 shares authorized and 12,000,000 Series B Preferred shares authorized, issued and outstanding	12,000	12,000
Common stock, $0.001 par value, 12,000,000,000 shares authorized; 7,064,727,214 and 7,039,727,214 shares issued and outstanding at December 31, 2023 and 2022, respectively	7,064,727	7,039,727
Common stock to be issued	469,678	469,678
Additional paid-in capital	53,630,761	53,653,261
Accumulated deficit	(74,945,474)	(73,552,118)
Total stockholders’ deficit	(13,768,308)	(12,377,452)
Total liabilities and stockholders’ deficit	$ 640,397	$ 754,913